Tirofiban, eptifibatide and abciximab in minimizing CK-MB release during coronary intervention (TEAM trial)

被引：0
|
作者：
Sharma, SK
Richard, M
Kini, AS
Suleman, J
Perez, N
King, T
Fisher, EA
Reich, D
Marmur, JD
机构：
[1] Mt Sinai Hosp, New York, NY 10029 USA
[2] Mt Sinai Med Ctr, New York, NY 10029 USA
[3] Mt Sinai Sch Med, New York, NY USA
[4] Mt Sinai Med Hosp, New York, NY USA
来源：
CIRCULATION | 2000年 / 102卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3216
引用
收藏
页码：665 / +
页数：2
相关论文
共 50 条
  • [41] Comparison of catheterization lab initiated abciximab and double-bolus eptifibatide during percutaneous coronary intervention in acute coronary syndromes: an ACUITY substudy
    Kirtane, Ajay J.
    Parise, Helen
    Mehran, Roxana
    Moses, Jeffrey W.
    Fahy, Martin
    Bertrand, Michel E.
    Ohman, E. Magnus
    White, Harvey D.
    Feit, Frederick
    Colombo, Antonio
    McLaurin, Brent T.
    Cox, David A.
    Ware, James H.
    Pocock, Stuart
    Stone, Gregg W.
    CIRCULATION, 2007, 116 (16) : 629 - 630
  • [42] Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutaneous coronary intervention in ESPRIT
    Bachour, FA
    Blankenship, JC
    Iliadis, EA
    Tasissa, G
    O'Shea, JC
    Kitt, MM
    Lorenz, TJ
    Tcheng, JE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 84A - 84A
  • [43] Effect of Sevoflurane on Serum CK-MB Levels After Percutaneous Coronary Stent Placement: A Prospective Randomized Clinical Trial
    Rossi Jr, Ronaldo
    Nigro, Caetano
    Braga, Sergio Navarro
    Sousa, Amanda G. M. R.
    Feres, Fausto
    Costa Jr, J. Ribamar
    JOURNAL OF INVASIVE CARDIOLOGY, 2023, 35 (12):
  • [44] Relationship between CK-MB increase after percutaneous coronary intervention and coronary plaque characteristics assessed by intravascular ultrasound and optical coherence tomography
    Lee, T.
    Kakuta, T.
    Yonetsu, T.
    Taguchi, S.
    Takahashi, K.
    Kawaguchi, N.
    Yamamoto, G.
    Fujiwara, H.
    EUROPEAN HEART JOURNAL, 2010, 31 : 793 - 793
  • [45] Comparison of platelet inhibition achieved with abciximab vs eptifibatide during percutaneous coronary intervention: Influence of platelet inhibition on clinical outcome
    Aguirre, FV
    Lam, W
    Gill, JB
    Trask, RV
    Mallavarapu, CT
    Rocha-Singh, KJ
    Mikell, FL
    Mishkel, GJ
    Mayer, SA
    Yakel, D
    Steen, MS
    Kachich, RL
    CIRCULATION, 2000, 102 (18) : 428 - 429
  • [46] Predictors and prognostic values of CK-MB cardiac enzyme elevation after coronary intervention with radiation treatment in in-stent restenosis
    Limpijankit, T
    Dangas, G
    Mehran, R
    Lansky, AA
    Stone, GW
    Kipshidze, N
    Astatkie, M
    Hawkey, M
    Ashby, D
    Mohamed, M
    Moussa, I
    Collins, MB
    Moses, JW
    Leon, MB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 23A - 23A
  • [47] Diabetes does not add to the increased six-month mortality associated with increase in CK-MB after percutaneous coronary intervention
    Puri, S
    Chaitman, BR
    Gavard, JA
    Sakai, S
    Stocks, K
    Erhardt, L
    Chi, E
    Jessel, A
    Gallo, R
    Theroux, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 55A - 55A
  • [48] Eptifibatide and Abciximab are associated with similar outcomes when used during Primary Percutaneous Coronary Intervention for ST-elevation myocardial infarction
    Ding, Nicola
    Jones, Daniel A.
    Peterzan, Mark
    Gallagher, Sean
    Antoniou, Sotiris
    Wright, Paul
    Rathod, Krishnaraj
    Jain, Ajay
    Knight, Charles
    Mathur, Anthony
    Weerackody, Roshan
    Wragg, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B48 - B48
  • [49] Eptifibatide and abciximab are associated with similar outcomes when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction
    Akhtar, M. M.
    Jones, D. A.
    Ding, N.
    Gallagher, S.
    Rathod, K. S.
    Jain, A.
    Knight, C.
    Mathur, A.
    Weerackody, R.
    Wragg, A.
    EUROPEAN HEART JOURNAL, 2013, 34 : 1024 - 1025
  • [50] In-lab angiographic complications during coronary intervention with abciximab vs placebo in the EPILOG trial
    Blankenship, JC
    Anderson, KM
    Demko, SL
    Lincoff, AM
    Tcheng, JE
    Cabot, CF
    CIRCULATION, 1997, 96 (08) : 905 - 905
12345